Astellas Completes Acquisition of Audentes Therapeutics

News
2020
2019
Archive

January 15, 2020

Astellas Completes Acquisition of Audentes Therapeutics
January 13, 2020

Pear Therapeutics Announces Collaboration with Apricity Health to Advance Prescription Digital Therapeutics to be Prescribed in Combination with Immuno-oncology Therapy
January 10, 2020

Akouos Announces Senior Leadership Team Appointments
January 10, 2020

Crossroads Treatment Centers Teams with Pear Therapeutics to Bring the First Ever Digital Therapy to an Opioid Addiction Treatment Program
January 10, 2020

Impel NeuroPharma Announces Appointment of Adrian Adams as Chairman of the Board of Directors
January 8, 2020

Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
January 8, 2020

Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People
January 7, 2020

Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer
January 7, 2020

Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutics and Digital Biomarker Technologies

1